Detalles de la búsqueda
1.
Patient preferences in the treatment of stage III/IV classic Hodgkin lymphoma: Results from the CONNECT cross-sectional survey.
Br J Haematol
; 204(4): 1262-1270, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38323849
2.
Physician frontline treatment preferences for stage III/IV classic Hodgkin lymphoma: the real-world US CONNECT study.
Future Oncol
; 20(12): 749-760, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37665273
3.
Retrospective Analysis With Propensity Score Matching of Peripheral T-Cell Lymphoma Treated Frontline With Brentuximab Vedotin and Chemotherapy.
Oncologist
; 28(6): 520-530, 2023 06 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36971492
4.
The impact of classic Hodgkin lymphoma on informal caregivers: results from the CONNECT cross-sectional survey.
Support Care Cancer
; 31(12): 664, 2023 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37914825
5.
Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas.
Blood
; 131(19): 2120-2124, 2018 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29507077
6.
Lenalidomide plus rituximab (R2 ) in previously untreated marginal zone lymphoma: subgroup analysis and long-term follow-up of an open-label phase 2 trial.
Br J Haematol
; 185(5): 874-882, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30919940
7.
Long-term overall- and progression-free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non-Hodgkin lymphoma.
Br J Haematol
; 185(4): 670-678, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30820940
8.
Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden.
Oncologist
; 24(2): 219-228, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30108156
9.
Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma.
Blood
; 130(4): 472-477, 2017 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28522441
10.
Outcome of patients with relapsed or refractory anaplastic large cell lymphoma who have failed brentuximab vedotin.
Hematol Oncol
; 37(1): 35-38, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30209819
11.
Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival ?
Ann Hematol
; 98(5): 1169-1176, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30617643
12.
Prevalence of a Histologic Change of Ocular Adnexal Lymphoma in Patients With a History of Lymphoma.
Ophthalmic Plast Reconstr Surg
; 35(3): 243-246, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30124609
13.
Pre-treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma.
Br J Haematol
; 180(4): 545-549, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29271057
14.
Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 23(11): 1826-1838, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28797780
15.
A multi-institutional analysis of peritransplantation radiotherapy in patients with relapsed/refractory Hodgkin lymphoma undergoing autologous stem cell transplantation.
Cancer
; 123(8): 1363-1371, 2017 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27984652
16.
High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study.
Br J Haematol
; 177(2): 263-270, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28340281
17.
The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
Br J Haematol
; 176(5): 750-758, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27983760
18.
Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 22(7): 1333-1337, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27064056
19.
Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma.
Cancer
; 122(20): 3145-3151, 2016 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27351173
20.
Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum ß2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model.
Br J Haematol
; 175(2): 290-299, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27448187